Contact
Please use this form to send email to PR contact of this press release:
Orphan Drug Designation Granted to PTX-252 by U.S. FDA for the Treatment of Acute Myeloid Leukaemia (AML)
TO:
Please use this form to send email to PR contact of this press release:
Orphan Drug Designation Granted to PTX-252 by U.S. FDA for the Treatment of Acute Myeloid Leukaemia (AML)
TO: